tirzepatide fat loss for Medical Weight Paving the Road to Tirzepatide

105 LippaiR.Veres-SzekelyA.SzikszE.IwakuraY.PapD.RokonayR.et al (2021)

Patients taking Wegovy at 2.4 mg may reduce the risk of Type 2 diabetes by as much as 60%

Front Plant Sci 6:1128

The pattern most often described now has two phases: Loading / tolerance phase: roughly 50 mcg 1 unit on a U-100 insulin syringe at the standard 10 mg / 2 mL reconstitution subcutaneously once daily for about 7 days in a row, or until noticeable color begins to appear

Glucagon-like peptide-1 as a multi-faceted modulator of inflammatory pathways and oxidative stress

That said, its important to note: there is no direct head-to-head clinical trial between Tirzepatide and Retatrutide yet